The rising prevalence of musculoskeletal disorders and technological advancements in product development are likely to drive the growth of the Demineralized Bone Fiber Technology market

November 03 01:52 2021
The rising prevalence of musculoskeletal disorders and technological advancements in product development are likely to drive the growth of the Demineralized Bone Fiber Technology market
Demineralized Bone Fiber Technology Market
The Demineralized Bone Fiber Technology market is expected to be driven by factors such as an increase in the geriatric population and an increase in the prevalence of musculoskeletal disorders such as degenerative disc disease, among others.

DelveInsight’s Demineralized Bone Fiber Technology market report provides an overview of Demineralized Bone Fiber Technology, its applications, and its PEST Analysis. Furthermore, the Demineralized Bone Fiber Technology report offers information on the individual Demineralized Bone Fiber Technology market share, as well as current and forecasted Demineralized Bone Fiber Technology market size from 2018 to 2026, segmented into 7MM (the United States, EU5 (Germany, France, Italy, the UK, and Spain), and Japan).

Key Highlights from the Demineralized Bone Fiber Technology Market Report

  • The major MedTech companies active in the Demineralized Bone Fiber Technology Include Zimmer Biomet, Medtronic, ATEC Spine Inc, TheraCell Inc., DePuy Synthes (Musculoskeletal Transplant Foundation), Nuvasive Inc, Evologics, Vivex Biologics Inc, Surgalign, Surgilogix, Innovasis Inc, and others.

  • The FDA-approved Demineralized Bone Fiber Technology products available in the market include FIBERFORM™+, GRAFTON™ DBF, Propel DBM fibers, Influx, Demin Cortical Fiber Strips, and others.

  • FIBERFORM+ (TheraCell Inc. ) is a moldable demineralized bone fiber form with mineralized cortical chips intended for use in orthopedic and spine surgery.

  • Medtronic’s GRAFTONTM DBF is a demineralized bone allograft made up of demineralized cortical fibers.

  • NuVasive’s Propel DBM fibers are made entirely of bone and are intended for homologous use in repairing, replacing, or reconstructing skeletal defects.

  • The Demineralized Bone Fiber Technology market is segmented by Product Type and End User.

Request for the Webex demo of the report @ Demineralized Bone Fiber Technology Market Outlook

Demineralized Bone Fiber: Overview

Demineralized Bone Fibers (DBF) are a demineralized bone matrix formulation that can provide favorable handling without using a carrier. To make DBF, allograft bone is demineralized into long fibers or ribbons rather than fine particulate, resulting in a DBF product that is cohesive on its own. Different fiber geometry and product configurations, on the other hand, can result in varying handling and biologic properties.

Demineralized Bone Fiber Technology Market 

In terms of product availability, the Demineralized Bone Fiber Technology market is highly diverse. The Demineralized Bone Fiber Technology market is expected to be driven by factors such as an increase in the geriatric population and an increase in the prevalence of musculoskeletal disorders such as degenerative disc disease, among others. Furthermore, rising technological advancements in product development are expected to propel the Demineralized Bone Fiber Technology market.

Find out which player or device is going to get the maximum share @ Demineralized Bone Fiber Technology Market Size

Demineralized Bone Fiber Technology Key Companies 

  • Zimmer Biomet

  • Medtronic

  • ATEC Spine Inc

  • TheraCell Inc.

  • DePuy Synthes (Musculoskeletal Transplant Foundation)

  • Nuvasive Inc

  • Evologics

  • Vivex Biologics Inc

  • Surgalign

  • Surgilogix

  • Innovasis Inc

Demineralized Bone Fiber Technology Market Drivers

  • The rise in the geriatric population

  • Technological advancements in product development such as biomaterials

  • Increase in variety of DBF products being released commercially, with variable fiber geometries and product configurations

Demineralized Bone Fiber Technology Market Barriers

  • Rejection of allografts

  • High product cost for end-users

Demineralized Bone Fiber Technology Unmet Needs 

  • Need for greater understanding of the factors affecting bone-forming capacity and fusion performance of DBFs

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-26

Demineralized Bone Fiber Technology Key Companies: Zimmer Biomet, Medtronic, ATEC Spine Inc, TheraCell Inc., DePuy Synthes (Musculoskeletal Transplant Foundation), Nuvasive Inc, Evologics, Vivex Biologics Inc, Surgalign, Surgilogix, Innovasis Inc, among others. 

Tools Used: PEST Analysis

KOL’s Views

Table of Contents

1.

Key Insights

2.

Executive Summary of  Demineralized Bone Fiber Technology 

3.

Demineralized Bone Fiber Technology: Background and Overview

4.

Demineralized Bone Fiber Technology: Regulatory Framework

5.

Demineralized Bone Fiber Technology: Regulatory Framework

6.

Demineralized Bone Fiber Technology Company Profiles

7.

Demineralized Bone Fiber Technology: Competitive Analysis of Listed Products

8.

Demineralized Bone Fiber Technology: KOL Views

9.

Demineralized Bone Fiber Technology: Market Analysis in 7MM

10.

Country-Wise Market size of  Demineralized Bone Fiber Technology in 7MM

11.

PEST Analysis

12.

Conclusion and Future Perspective

13.

Appendix

14.

DelveInsight Capabilities

15.

Disclaimer

16.

About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Bone Densitometers Market 

Get a comprehensive analysis of Bone Densitometers pipeline devices and key companies including General Electric Company, Hologic, Inc., Swissray, Osteosys Co. Ltd, MedWrench, LLC, Schick Sirona, DMS Imaging, Echolight S.p.a., Aarna Systems And Wellness Pvt. Ltd, Tecnicare Healthcare Company, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

view more articles

About Article Author